{"id":348567,"date":"2026-11-16T14:12:50","date_gmt":"2026-11-16T08:42:50","guid":{"rendered":"https:\/\/univest.in\/blogs-2\/?p=348567"},"modified":"2026-11-16T14:12:50","modified_gmt":"2026-11-16T08:42:50","slug":"garments-exporter-generic-pharma-maker-and-batteries-and-defence-electronics-maker-stocks-roadmap-moorland-list","status":"publish","type":"post","link":"https:\/\/univest.in\/blogs-2\/garments-exporter-generic-pharma-maker-and-batteries-and-defence-electronics-maker-stocks-roadmap-moorland-list\/","title":{"rendered":"3 Garments Exporter, Generic Pharma Maker and Batteries and Defence Electronics Maker Stocks With a Strong Future Roadmap: Pearl Global Industries, Strides Pharma Science and HBL Engineering"},"content":{"rendered":"<p style=\"border-left:4px solid #1F4E84;background:#EBF3FB;padding:10px 16px;font-style:italic;\"><em>Pearl Global Industries, Strides Pharma Science and HBL Engineering: ROE of 17.9% to 36.8% and FY22 to FY26 revenue CAGR of 11.8% to 28.0%. Prices as of 13 Nov 2026.<\/em><\/p>\n<div style=\"background:#F0F9FF;border-left:4px solid #2E7D32;border-radius:6px;padding:14px 18px;margin:18px 0;\">\n<p style=\"margin:0;color:#1F4E84;font-size:14px;\"><strong>Quick Answer<\/strong><\/p>\n<p style=\"margin:8px 0 0;\">The three apparel export, pharma and defence cell stocks to watch are Pearl Global Industries, Strides Pharma Science and HBL Engineering. Their return on equity ranges from 17.9% to 36.8%, and their revenue compound annual growth from FY22 to FY26 ranges from 11.8% to 28.0%. HBL Engineering leads on both return on equity at 36.8% and revenue growth at 28.0% a year. Prices are based on the 13 November 2026 close, and this article is educational, not investment advice.<\/p>\n<\/div>\n<p>Apparel export, pharma and defence cell stocks give investors a way to track businesses that sit close to everyday demand in India. Pearl Global Industries, Strides Pharma Science and HBL Engineering cover a garments exporter, a generic pharma maker and a batteries and defence electronics maker.<\/p>\n<p>This list covers three apparel export, pharma and defence cell stocks with complete current figures: Pearl Global Industries, Strides Pharma Science and HBL Engineering. Every figure comes from the latest reported financials and the 13 November 2026 market close. Companies without complete current figures were left out.<\/p>\n<p style=\"margin-top:24px;\"><strong><a href=\"https:\/\/univest.in\/user\/log-in?utm_source=blogs&#038;utm_medium=garments-exporter-generic-pharma-maker-and-batteries-and-defence-electronics-maker-stocks-roadmap-moorland-list\">Click Here &#8211; Get Free Investment Predictions<\/a><\/strong><\/p>\n<div id=\"ez-toc-container\" class=\"ez-toc-v2_0_65 counter-hierarchy ez-toc-counter ez-toc-grey ez-toc-container-direction\">\n<div class=\"ez-toc-title-container\">\n<p class=\"ez-toc-title \" >Table of Contents<\/p>\n<span class=\"ez-toc-title-toggle\"><a href=\"#\" class=\"ez-toc-pull-right ez-toc-btn ez-toc-btn-xs ez-toc-btn-default ez-toc-toggle\" aria-label=\"Toggle Table of Content\"><span class=\"ez-toc-js-icon-con\"><span class=\"\"><span class=\"eztoc-hide\" style=\"display:none;\">Toggle<\/span><span class=\"ez-toc-icon-toggle-span\"><svg style=\"fill: #999;color:#999\" xmlns=\"http:\/\/www.w3.org\/2000\/svg\" class=\"list-377408\" width=\"20px\" height=\"20px\" viewBox=\"0 0 24 24\" fill=\"none\"><path d=\"M6 6H4v2h2V6zm14 0H8v2h12V6zM4 11h2v2H4v-2zm16 0H8v2h12v-2zM4 16h2v2H4v-2zm16 0H8v2h12v-2z\" fill=\"currentColor\"><\/path><\/svg><svg style=\"fill: #999;color:#999\" class=\"arrow-unsorted-368013\" xmlns=\"http:\/\/www.w3.org\/2000\/svg\" width=\"10px\" height=\"10px\" viewBox=\"0 0 24 24\" version=\"1.2\" baseProfile=\"tiny\"><path d=\"M18.2 9.3l-6.2-6.3-6.2 6.3c-.2.2-.3.4-.3.7s.1.5.3.7c.2.2.4.3.7.3h11c.3 0 .5-.1.7-.3.2-.2.3-.5.3-.7s-.1-.5-.3-.7zM5.8 14.7l6.2 6.3 6.2-6.3c.2-.2.3-.5.3-.7s-.1-.5-.3-.7c-.2-.2-.4-.3-.7-.3h-11c-.3 0-.5.1-.7.3-.2.2-.3.5-.3.7s.1.5.3.7z\"\/><\/svg><\/span><\/span><\/span><\/a><\/span><\/div>\n<nav><ul class='ez-toc-list ez-toc-list-level-1 ' ><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-1\" href=\"https:\/\/univest.in\/blogs-2\/garments-exporter-generic-pharma-maker-and-batteries-and-defence-electronics-maker-stocks-roadmap-moorland-list\/#What_Are_Apparel_Export_Pharma_and_Defence_Cell_Stocks\" title=\"What Are Apparel Export, Pharma and Defence Cell Stocks?\">What Are Apparel Export, Pharma and Defence Cell Stocks?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-2\" href=\"https:\/\/univest.in\/blogs-2\/garments-exporter-generic-pharma-maker-and-batteries-and-defence-electronics-maker-stocks-roadmap-moorland-list\/#Apparel_Export_Pharma_and_Defence_Cell_Stocks_at_a_Glance\" title=\"Apparel Export, Pharma and Defence Cell Stocks at a Glance\">Apparel Export, Pharma and Defence Cell Stocks at a Glance<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-3\" href=\"https:\/\/univest.in\/blogs-2\/garments-exporter-generic-pharma-maker-and-batteries-and-defence-electronics-maker-stocks-roadmap-moorland-list\/#Why_Do_Apparel_Export_Pharma_and_Defence_Cell_Stocks_Have_a_Strong_Roadmap_in_India\" title=\"Why Do Apparel Export, Pharma and Defence Cell Stocks Have a Strong Roadmap in India?\">Why Do Apparel Export, Pharma and Defence Cell Stocks Have a Strong Roadmap in India?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-4\" href=\"https:\/\/univest.in\/blogs-2\/garments-exporter-generic-pharma-maker-and-batteries-and-defence-electronics-maker-stocks-roadmap-moorland-list\/#Why_Pearl_Global_Industries_Features_Among_These_Apparel_Export_Pharma_and_Defence_Cell_Stocks\" title=\"Why Pearl Global Industries Features Among These Apparel Export, Pharma and Defence Cell Stocks\">Why Pearl Global Industries Features Among These Apparel Export, Pharma and Defence Cell Stocks<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-5\" href=\"https:\/\/univest.in\/blogs-2\/garments-exporter-generic-pharma-maker-and-batteries-and-defence-electronics-maker-stocks-roadmap-moorland-list\/#Why_Strides_Pharma_Science_Features_Among_These_Apparel_Export_Pharma_and_Defence_Cell_Stocks\" title=\"Why Strides Pharma Science Features Among These Apparel Export, Pharma and Defence Cell Stocks\">Why Strides Pharma Science Features Among These Apparel Export, Pharma and Defence Cell Stocks<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-6\" href=\"https:\/\/univest.in\/blogs-2\/garments-exporter-generic-pharma-maker-and-batteries-and-defence-electronics-maker-stocks-roadmap-moorland-list\/#Why_HBL_Engineering_Features_Among_These_Apparel_Export_Pharma_and_Defence_Cell_Stocks\" title=\"Why HBL Engineering Features Among These Apparel Export, Pharma and Defence Cell Stocks\">Why HBL Engineering Features Among These Apparel Export, Pharma and Defence Cell Stocks<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-7\" href=\"https:\/\/univest.in\/blogs-2\/garments-exporter-generic-pharma-maker-and-batteries-and-defence-electronics-maker-stocks-roadmap-moorland-list\/#Pearl_Global_Industries_vs_Strides_Pharma_Science_vs_HBL_Engineering_on_Key_Financials\" title=\"Pearl Global Industries vs Strides Pharma Science vs HBL Engineering on Key Financials\">Pearl Global Industries vs Strides Pharma Science vs HBL Engineering on Key Financials<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-8\" href=\"https:\/\/univest.in\/blogs-2\/garments-exporter-generic-pharma-maker-and-batteries-and-defence-electronics-maker-stocks-roadmap-moorland-list\/#Key_Risks_to_Check_Before_Investing_in_Apparel_Export_Pharma_and_Defence_Cell_Stocks\" title=\"Key Risks to Check Before Investing in Apparel Export, Pharma and Defence Cell Stocks\">Key Risks to Check Before Investing in Apparel Export, Pharma and Defence Cell Stocks<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-9\" href=\"https:\/\/univest.in\/blogs-2\/garments-exporter-generic-pharma-maker-and-batteries-and-defence-electronics-maker-stocks-roadmap-moorland-list\/#Final_Thoughts_on_Apparel_Export_Pharma_and_Defence_Cell_Stocks\" title=\"Final Thoughts on Apparel Export, Pharma and Defence Cell Stocks\">Final Thoughts on Apparel Export, Pharma and Defence Cell Stocks<\/a><ul class='ez-toc-list-level-3' ><li class='ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-10\" href=\"https:\/\/univest.in\/blogs-2\/garments-exporter-generic-pharma-maker-and-batteries-and-defence-electronics-maker-stocks-roadmap-moorland-list\/#What_are_apparel_export_pharma_and_defence_cell_stocks\" title=\"What are apparel export, pharma and defence cell stocks?\">What are apparel export, pharma and defence cell stocks?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-11\" href=\"https:\/\/univest.in\/blogs-2\/garments-exporter-generic-pharma-maker-and-batteries-and-defence-electronics-maker-stocks-roadmap-moorland-list\/#Which_apparel_export_pharma_and_defence_cell_stocks_are_covered_in_this_list\" title=\"Which apparel export, pharma and defence cell stocks are covered in this list?\">Which apparel export, pharma and defence cell stocks are covered in this list?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-12\" href=\"https:\/\/univest.in\/blogs-2\/garments-exporter-generic-pharma-maker-and-batteries-and-defence-electronics-maker-stocks-roadmap-moorland-list\/#Why_do_apparel_export_pharma_and_defence_cell_stocks_have_a_strong_future_roadmap_in_India\" title=\"Why do apparel export, pharma and defence cell stocks have a strong future roadmap in India?\">Why do apparel export, pharma and defence cell stocks have a strong future roadmap in India?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-13\" href=\"https:\/\/univest.in\/blogs-2\/garments-exporter-generic-pharma-maker-and-batteries-and-defence-electronics-maker-stocks-roadmap-moorland-list\/#How_has_Pearl_Global_Industries_performed_financially\" title=\"How has Pearl Global Industries performed financially?\">How has Pearl Global Industries performed financially?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-14\" href=\"https:\/\/univest.in\/blogs-2\/garments-exporter-generic-pharma-maker-and-batteries-and-defence-electronics-maker-stocks-roadmap-moorland-list\/#How_has_Strides_Pharma_Science_performed_financially\" title=\"How has Strides Pharma Science performed financially?\">How has Strides Pharma Science performed financially?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-15\" href=\"https:\/\/univest.in\/blogs-2\/garments-exporter-generic-pharma-maker-and-batteries-and-defence-electronics-maker-stocks-roadmap-moorland-list\/#How_has_HBL_Engineering_performed_financially\" title=\"How has HBL Engineering performed financially?\">How has HBL Engineering performed financially?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-16\" href=\"https:\/\/univest.in\/blogs-2\/garments-exporter-generic-pharma-maker-and-batteries-and-defence-electronics-maker-stocks-roadmap-moorland-list\/#What_risks_should_investors_check_before_buying_apparel_export_pharma_and_defence_cell_stocks\" title=\"What risks should investors check before buying apparel export, pharma and defence cell stocks?\">What risks should investors check before buying apparel export, pharma and defence cell stocks?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-17\" href=\"https:\/\/univest.in\/blogs-2\/garments-exporter-generic-pharma-maker-and-batteries-and-defence-electronics-maker-stocks-roadmap-moorland-list\/#Is_this_list_of_apparel_export_pharma_and_defence_cell_stocks_investment_advice\" title=\"Is this list of apparel export, pharma and defence cell stocks investment advice?\">Is this list of apparel export, pharma and defence cell stocks investment advice?<\/a><\/li><\/ul><\/li><\/ul><\/nav><\/div>\n<h2><span class=\"ez-toc-section\" id=\"What_Are_Apparel_Export_Pharma_and_Defence_Cell_Stocks\"><\/span><strong>What Are Apparel Export, Pharma and Defence Cell Stocks?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>Apparel export, pharma and defence cell stocks are listed companies that design and export readymade garments to global brands, make generic medicines and ingredients, and make industrial batteries, defence electronics and railway safety systems. Their earnings depend on export orders, medicine demand and defence and rail orders.<\/p>\n<h2><span class=\"ez-toc-section\" id=\"Apparel_Export_Pharma_and_Defence_Cell_Stocks_at_a_Glance\"><\/span><strong>Apparel Export, Pharma and Defence Cell Stocks at a Glance<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<div style=\"overflow-x:auto;\">\n<table style=\"border-collapse:collapse;width:100%;\">\n<thead>\n<tr>\n<th style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;background:#F0F4F8;\">Company<\/th>\n<th style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;background:#F0F4F8;\">CMP (Rs)<\/th>\n<th style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;background:#F0F4F8;\">Market Cap (Rs Cr)<\/th>\n<th style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;background:#F0F4F8;\">P\/E<\/th>\n<th style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;background:#F0F4F8;\">Industry P\/E<\/th>\n<th style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;background:#F0F4F8;\">ROE (%)<\/th>\n<th style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;background:#F0F4F8;\">D\/E<\/th>\n<\/tr>\n<\/thead>\n<tbody>\n<tr>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\"><a href=\"https:\/\/univest.in\/stocks\/pgil\/pearl-global-industries-ltd-share-price-today\">Pearl Global Industries<\/a><\/td>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">1,333.1<\/td>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">11,806<\/td>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">38.9<\/td>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">35.2<\/td>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">19.0<\/td>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">0.65<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\"><a href=\"https:\/\/univest.in\/stocks\/star\/strides-pharma-science-ltd-share-price-today\">Strides Pharma Science<\/a><\/td>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">1,014.6<\/td>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">9,491<\/td>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">15.0<\/td>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">36.0<\/td>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">17.9<\/td>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">0.57<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\"><a href=\"https:\/\/univest.in\/stocks\/hblengine\/hbl-engineering-ltd-share-price-today\">HBL Engineering<\/a><\/td>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">799.55<\/td>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">22,507<\/td>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">28.8<\/td>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">36.9<\/td>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">36.8<\/td>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">0.03<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<\/div>\n<p>On valuation, Strides Pharma Science and HBL Engineering trade at a P\/E below the industry P\/E, while Pearl Global Industries trades above it, which reflects the growth the market already expects. Readers comparing apparel export, pharma and defence cell stocks should look at return on equity and debt together, since a high return earned with low debt is easier to sustain. With the Q2 FY27 results season close, investors in apparel export, pharma and defence cell stocks can use the coming numbers to test whether growth is holding.<\/p>\n<h2><span class=\"ez-toc-section\" id=\"Why_Do_Apparel_Export_Pharma_and_Defence_Cell_Stocks_Have_a_Strong_Roadmap_in_India\"><\/span><strong>Why Do Apparel Export, Pharma and Defence Cell Stocks Have a Strong Roadmap in India?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>Apparel export, pharma and defence cell stocks have a strong roadmap in India because strong global sourcing from India, wider access to quality medicines and rising defence and railway spending keep widening the market for these companies.<\/p>\n<ul>\n<li><strong>Garments export.<\/strong> Global brands source more from India.<\/li>\n<li><strong>Generic pharma.<\/strong> Patients need affordable medicines.<\/li>\n<li><strong>Batteries and defence electronics.<\/strong> Defence and rail need advanced systems.<\/li>\n<\/ul>\n<h2><span class=\"ez-toc-section\" id=\"Why_Pearl_Global_Industries_Features_Among_These_Apparel_Export_Pharma_and_Defence_Cell_Stocks\"><\/span><strong>Why Pearl Global Industries Features Among These Apparel Export, Pharma and Defence Cell Stocks<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>Among the apparel export, pharma and defence cell stocks on this list, Pearl Global Industries is a Gurugram-based apparel manufacturer and exporter that makes garments for leading international brands from factories in India, Bangladesh, Vietnam and Indonesia.<\/p>\n<p>In the June 2026 quarter, revenue grew 24.2% year on year to Rs 1,539 crore, while net profit rose 51.4% to Rs 99.2 crore. Revenue rose from Rs 2,747 crore in FY22 to Rs 5,062 crore in FY26, a compound annual growth rate of 16.5%.<\/p>\n<p>Net profit grew from Rs 70.1 crore in FY22 to Rs 270 crore in FY26, which works out to a compound annual growth rate of 40.1%. The company has a return on equity of 19.0%, a debt to equity ratio of 0.65 and a market capitalisation of Rs 11,806 crore. The stock trades at a P\/E of 38.9, above the industry P\/E of 35.2.<\/p>\n<p><strong>Roadmap:<\/strong> The company benefits from global brands diversifying their sourcing away from a single country, and its multi-country footprint helps it serve them. Capacity additions and a growing retail brand portfolio add to its growth levers.<\/p>\n<p><strong>What to watch:<\/strong> Watch order inflow from global brands and the ramp-up of newer factories.<\/p>\n<h2><span class=\"ez-toc-section\" id=\"Why_Strides_Pharma_Science_Features_Among_These_Apparel_Export_Pharma_and_Defence_Cell_Stocks\"><\/span><strong>Why Strides Pharma Science Features Among These Apparel Export, Pharma and Defence Cell Stocks<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>Among the garment exporter, medicine maker and cell shares on this list, Strides Pharma Science, based in Bengaluru, makes finished dosage generics for the United States and other regulated markets, with oral solids and soft gel capsules as important product groups.<\/p>\n<p>The company has a return on equity of 17.9%, a debt to equity ratio of 0.57 and a market capitalisation of Rs 9,491 crore. The stock trades at a P\/E of 15.0, below the industry P\/E of 36.0.<\/p>\n<p>Revenue rose from Rs 3,202 crore in FY22 to Rs 5,009 crore in FY26, a compound annual growth rate of 11.8%. Net profit grew from Rs 409 crore in FY25 to Rs 575 crore in FY26, a rise of 40.3%. In the June 2026 quarter, revenue grew 12.6% year on year to Rs 1,270 crore, while net profit rose 56.7% to Rs 165 crore.<\/p>\n<p><strong>Roadmap:<\/strong> The company is leaning on new product launches in its regulated-market pipeline and improving utilisation of its plants. Profit can rise faster than revenue as volumes build on an existing cost base.<\/p>\n<p><strong>What to watch:<\/strong> Track new US launches and the pace of price erosion in generic categories.<\/p>\n<h2><span class=\"ez-toc-section\" id=\"Why_HBL_Engineering_Features_Among_These_Apparel_Export_Pharma_and_Defence_Cell_Stocks\"><\/span><strong>Why HBL Engineering Features Among These Apparel Export, Pharma and Defence Cell Stocks<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>Among the three companies on this list, HBL Engineering, formerly HBL Power Systems, makes specialised batteries, defence electronics, railway safety systems, and electronics for aerospace and industrial use.<\/p>\n<p>Revenue rose from Rs 1,251 crore in FY22 to Rs 3,362 crore in FY26, a compound annual growth rate of 28.0%. Net profit grew from Rs 93.7 crore in FY22 to Rs 814 crore in FY26, which works out to a compound annual growth rate of 71.7%.<\/p>\n<p>In the June 2026 quarter, revenue grew 6.0% year on year to Rs 659 crore. The company has a return on equity of 36.8%, a debt to equity ratio of 0.03 and a market capitalisation of Rs 22,507 crore. The stock trades at a P\/E of 28.8, below the industry P\/E of 36.9.<\/p>\n<p><strong>Roadmap:<\/strong> The company has grown its defence electronics and railway safety businesses, including systems for collision avoidance, and is expanding its battery lines. Orders from railways and defence customers provide a long runway.<\/p>\n<p><strong>What to watch:<\/strong> Monitor large railway and defence orders and their execution schedules.<\/p>\n<h2><span class=\"ez-toc-section\" id=\"Pearl_Global_Industries_vs_Strides_Pharma_Science_vs_HBL_Engineering_on_Key_Financials\"><\/span><strong>Pearl Global Industries vs Strides Pharma Science vs HBL Engineering on Key Financials<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>The table below sets the three apparel export, pharma and defence cell stocks side by side on revenue, profit and margin, using reported figures.<\/p>\n<div style=\"overflow-x:auto;\">\n<table style=\"border-collapse:collapse;width:100%;\">\n<thead>\n<tr>\n<th style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;background:#F0F4F8;\">Company<\/th>\n<th style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;background:#F0F4F8;\">FY22 Revenue (Rs Cr)<\/th>\n<th style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;background:#F0F4F8;\">FY26 Revenue (Rs Cr)<\/th>\n<th style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;background:#F0F4F8;\">Revenue CAGR (FY22-FY26)<\/th>\n<th style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;background:#F0F4F8;\">FY26 Net Profit (Rs Cr)<\/th>\n<th style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;background:#F0F4F8;\">FY26 Net Margin<\/th>\n<\/tr>\n<\/thead>\n<tbody>\n<tr>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">Pearl Global Industries<\/td>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">2,747<\/td>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">5,062<\/td>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">16.5%<\/td>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">270<\/td>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">5.3%<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">Strides Pharma Science<\/td>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">3,202<\/td>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">5,009<\/td>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">11.8%<\/td>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">575<\/td>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">11.5%<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">HBL Engineering<\/td>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">1,251<\/td>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">3,362<\/td>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">28.0%<\/td>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">814<\/td>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">24.2%<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<\/div>\n<p>HBL Engineering posts the highest return on equity in this group at 36.8%. Pearl Global Industries has the largest FY26 revenue at Rs 5,062 crore, and HBL Engineering shows the fastest revenue growth with a 28.0% compound annual rate. A useful habit with apparel export, pharma and defence cell stocks is to check each new quarterly result against the capacity plans the company described earlier. Many investors spread money across several readymade garments, generics and power storage stocks instead of one name, which keeps a single result from deciding the outcome.<\/p>\n<p>The June 2026 quarter, the latest reported, gives a fresh read on momentum:<\/p>\n<div style=\"overflow-x:auto;\">\n<table style=\"border-collapse:collapse;width:100%;\">\n<thead>\n<tr>\n<th style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;background:#F0F4F8;\">Company<\/th>\n<th style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;background:#F0F4F8;\">Q1 FY26 Revenue (Rs Cr)<\/th>\n<th style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;background:#F0F4F8;\">Q1 FY27 Revenue (Rs Cr)<\/th>\n<th style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;background:#F0F4F8;\">Year-on-Year Growth<\/th>\n<\/tr>\n<\/thead>\n<tbody>\n<tr>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">Pearl Global Industries<\/td>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">1,239<\/td>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">1,539<\/td>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">24.2%<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">Strides Pharma Science<\/td>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">1,128<\/td>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">1,270<\/td>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">12.6%<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">HBL Engineering<\/td>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">621<\/td>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">659<\/td>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">6.0%<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<\/div>\n<h2><span class=\"ez-toc-section\" id=\"Key_Risks_to_Check_Before_Investing_in_Apparel_Export_Pharma_and_Defence_Cell_Stocks\"><\/span><strong>Key Risks to Check Before Investing in Apparel Export, Pharma and Defence Cell Stocks<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>Every theme carries risks that deserve a check before any decision. For these apparel export, pharma and defence cell stocks, the main points are: Long-term garment exporter, medicine maker and cell shares holders usually track revenue growth, margins and cash flow side by side rather than relying on a single ratio.<\/p>\n<ul>\n<li><strong>Currency moves.<\/strong> Export earnings move with the rupee.<\/li>\n<li><strong>Regulatory approvals.<\/strong> Plant inspections and approvals can affect supplies.<\/li>\n<li><strong>Order timing.<\/strong> Defence and space orders can shift between periods.<\/li>\n<\/ul>\n<p>Treat this list as a starting point for research and not as a recommendation. Read the latest results presentation, check the management commentary on order books or capacity plans, and compare each company with its peers before you decide anything.<\/p>\n<p style=\"margin-top:24px;\"><strong><a href=\"https:\/\/univest.in\/screeners\">Use the Univest Stock Screener<\/a><\/strong> to filter apparel export, pharma and defence cell stocks by market capitalisation, P\/E, ROE and growth, and build your own shortlist.<\/p>\n<h2><span class=\"ez-toc-section\" id=\"Final_Thoughts_on_Apparel_Export_Pharma_and_Defence_Cell_Stocks\"><\/span><strong>Final Thoughts on Apparel Export, Pharma and Defence Cell Stocks<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>Apparel export, pharma and defence cell stocks work best when investors track growth, valuation and return on equity side by side. Pearl Global Industries, Strides Pharma Science and HBL Engineering each have a clear plan to grow. Based on the 13 November 2026 close, Pearl Global Industries trades at Rs 1,333.1, Strides Pharma Science at Rs 1,014.6 and HBL Engineering at Rs 799.55. Valuation matters as much as growth, so compare each company&#8217;s P\/E with its industry P\/E before adding any of these apparel export, pharma and defence cell stocks to a watchlist.<\/p>\n<p style=\"margin-top:24px;\"><em>Download the <a href=\"http:\/\/apps.apple.com\/in\/app\/univest-stocks-investment\/id6443753518\" rel=\"nofollow noopener\" target=\"_blank\">Univest iOS App<\/a> or <a href=\"http:\/\/play.google.com\/store\/apps\/details?id=com.univest.capp&#038;hl=en_IN\" rel=\"nofollow noopener\" target=\"_blank\">Univest Android App<\/a> to track apparel export, pharma and defence cell stocks, set price alerts and get research-backed stock ideas.<\/em><\/p>\n<div style=\"background:#CC0000;border-radius:8px;padding:16px 20px;margin:24px 0;\">\n<p style=\"color:#FFFFFF;font-size:13px;line-height:1.7;margin:0;\"><strong style=\"color:#FFFFFF;\">Disclaimer:<\/strong> Data and figures in this article are sourced from publicly available information. These may or may not be accurate. Please verify all data with the official NSE (nseindia.com) and BSE (bseindia.com) websites before making any investment decision. Investments in securities are subject to market risk. This content is for educational purposes only and is not investment advice by Univest (SEBI RA INH000013776).<\/p>\n<\/div>\n<h3><span class=\"ez-toc-section\" id=\"What_are_apparel_export_pharma_and_defence_cell_stocks\"><\/span><strong>What are apparel export, pharma and defence cell stocks?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> Apparel export, pharma and defence cell stocks are listed companies that design and export readymade garments to global brands, make generic medicines and ingredients, and make industrial batteries, defence electronics and railway safety systems. Their earnings depend on export orders, medicine demand and defence and rail orders. This list looks at three of them, Pearl Global Industries, Strides Pharma Science and HBL Engineering, using reported FY22 to FY26 financials and the 13 November 2026 closing prices.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"Which_apparel_export_pharma_and_defence_cell_stocks_are_covered_in_this_list\"><\/span><strong>Which apparel export, pharma and defence cell stocks are covered in this list?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> This list covers Pearl Global Industries, Strides Pharma Science and HBL Engineering. Based on the 13 November 2026 close, Pearl Global Industries traded at Rs 1,333.1, Strides Pharma Science at Rs 1,014.6 and HBL Engineering at Rs 799.55. Their return on equity ranges from 17.9% to 36.8%, and their revenue compound annual growth from FY22 to FY26 ranges from 11.8% to 28.0%.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"Why_do_apparel_export_pharma_and_defence_cell_stocks_have_a_strong_future_roadmap_in_India\"><\/span><strong>Why do apparel export, pharma and defence cell stocks have a strong future roadmap in India?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> Apparel export, pharma and defence cell stocks have a strong roadmap in India because strong global sourcing from India, wider access to quality medicines and rising defence and railway spending keep widening the market for these companies. The main drivers are as follows. Garments export. Global brands source more from India. Generic pharma. Patients need affordable medicines. Batteries and defence electronics. Defence and rail need advanced systems. Together these factors give the companies on this list a visible path for growth over the coming years.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"How_has_Pearl_Global_Industries_performed_financially\"><\/span><strong>How has Pearl Global Industries performed financially?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> Revenue rose from Rs 2,747 crore in FY22 to Rs 5,062 crore in FY26, a compound annual growth rate of 16.5%. Net profit grew from Rs 70.1 crore in FY22 to Rs 270 crore in FY26, which works out to a compound annual growth rate of 40.1%. In the June 2026 quarter, revenue grew 24.2% year on year to Rs 1,539 crore, while net profit rose 51.4% to Rs 99.2 crore. The company has a return on equity of 19.0%, a debt to equity ratio of 0.65 and a market capitalisation of Rs 11,806 crore. The stock trades at a P\/E of 38.9, above the industry P\/E of 35.2. Looking ahead, the company benefits from global brands diversifying their sourcing away from a single country, and its multi-country footprint helps it serve them. Capacity additions and a growing retail brand portfolio add to its growth levers.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"How_has_Strides_Pharma_Science_performed_financially\"><\/span><strong>How has Strides Pharma Science performed financially?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> Revenue rose from Rs 3,202 crore in FY22 to Rs 5,009 crore in FY26, a compound annual growth rate of 11.8%. Net profit grew from Rs 409 crore in FY25 to Rs 575 crore in FY26, a rise of 40.3%. In the June 2026 quarter, revenue grew 12.6% year on year to Rs 1,270 crore, while net profit rose 56.7% to Rs 165 crore. The company has a return on equity of 17.9%, a debt to equity ratio of 0.57 and a market capitalisation of Rs 9,491 crore. The stock trades at a P\/E of 15.0, below the industry P\/E of 36.0. Looking ahead, the company is leaning on new product launches in its regulated-market pipeline and improving utilisation of its plants. Profit can rise faster than revenue as volumes build on an existing cost base.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"How_has_HBL_Engineering_performed_financially\"><\/span><strong>How has HBL Engineering performed financially?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> Revenue rose from Rs 1,251 crore in FY22 to Rs 3,362 crore in FY26, a compound annual growth rate of 28.0%. Net profit grew from Rs 93.7 crore in FY22 to Rs 814 crore in FY26, which works out to a compound annual growth rate of 71.7%. In the June 2026 quarter, revenue grew 6.0% year on year to Rs 659 crore. The company has a return on equity of 36.8%, a debt to equity ratio of 0.03 and a market capitalisation of Rs 22,507 crore. The stock trades at a P\/E of 28.8, below the industry P\/E of 36.9. Looking ahead, the company has grown its defence electronics and railway safety businesses, including systems for collision avoidance, and is expanding its battery lines. Orders from railways and defence customers provide a long runway.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"What_risks_should_investors_check_before_buying_apparel_export_pharma_and_defence_cell_stocks\"><\/span><strong>What risks should investors check before buying apparel export, pharma and defence cell stocks?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> Investors should check a few risks before buying apparel export, pharma and defence cell stocks. Currency moves. Export earnings move with the rupee. Regulatory approvals. Plant inspections and approvals can affect supplies. Order timing. Defence and space orders can shift between periods. Reading the latest results presentation and comparing each company with its peers helps judge how these risks apply to each stock.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"Is_this_list_of_apparel_export_pharma_and_defence_cell_stocks_investment_advice\"><\/span><strong>Is this list of apparel export, pharma and defence cell stocks investment advice?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> No. This article is educational and uses publicly available data as of the 13 November 2026 close. Please verify figures on NSE and BSE, read company filings and consult a SEBI registered adviser before investing. Univest is SEBI registered research analyst INH000013776.<\/p>\n<div class=\"faq-schema\"><script type=\"application\/ld+json\">{\"@context\":\"https:\/\/schema.org\",\"@type\":\"FAQPage\",\"mainEntity\":[{\"@type\":\"Question\",\"name\":\"What are apparel export, pharma and defence cell stocks?\",\"acceptedAnswer\":{\"@type\":\"Answer\",\"text\":\"Apparel export, pharma and defence cell stocks are listed companies that design and export readymade garments to global brands, make generic medicines and ingredients, and make industrial batteries, defence electronics and railway safety systems. Their earnings depend on export orders, medicine demand and defence and rail orders. This list looks at three of them, Pearl Global Industries, Strides Pharma Science and HBL Engineering, using reported FY22 to FY26 financials and the 13 November 2026 closing prices.\"}},{\"@type\":\"Question\",\"name\":\"Which apparel export, pharma and defence cell stocks are covered in this list?\",\"acceptedAnswer\":{\"@type\":\"Answer\",\"text\":\"This list covers Pearl Global Industries, Strides Pharma Science and HBL Engineering. Based on the 13 November 2026 close, Pearl Global Industries traded at Rs 1,333.1, Strides Pharma Science at Rs 1,014.6 and HBL Engineering at Rs 799.55. Their return on equity ranges from 17.9% to 36.8%, and their revenue compound annual growth from FY22 to FY26 ranges from 11.8% to 28.0%.\"}},{\"@type\":\"Question\",\"name\":\"Why do apparel export, pharma and defence cell stocks have a strong future roadmap in India?\",\"acceptedAnswer\":{\"@type\":\"Answer\",\"text\":\"Apparel export, pharma and defence cell stocks have a strong roadmap in India because strong global sourcing from India, wider access to quality medicines and rising defence and railway spending keep widening the market for these companies. The main drivers are as follows. Garments export. Global brands source more from India. Generic pharma. Patients need affordable medicines. Batteries and defence electronics. Defence and rail need advanced systems. Together these factors give the companies on this list a visible path for growth over the coming years.\"}},{\"@type\":\"Question\",\"name\":\"How has Pearl Global Industries performed financially?\",\"acceptedAnswer\":{\"@type\":\"Answer\",\"text\":\"Revenue rose from Rs 2,747 crore in FY22 to Rs 5,062 crore in FY26, a compound annual growth rate of 16.5%. Net profit grew from Rs 70.1 crore in FY22 to Rs 270 crore in FY26, which works out to a compound annual growth rate of 40.1%. In the June 2026 quarter, revenue grew 24.2% year on year to Rs 1,539 crore, while net profit rose 51.4% to Rs 99.2 crore. The company has a return on equity of 19.0%, a debt to equity ratio of 0.65 and a market capitalisation of Rs 11,806 crore. The stock trades at a P\/E of 38.9, above the industry P\/E of 35.2. Looking ahead, the company benefits from global brands diversifying their sourcing away from a single country, and its multi-country footprint helps it serve them. Capacity additions and a growing retail brand portfolio add to its growth levers.\"}},{\"@type\":\"Question\",\"name\":\"How has Strides Pharma Science performed financially?\",\"acceptedAnswer\":{\"@type\":\"Answer\",\"text\":\"Revenue rose from Rs 3,202 crore in FY22 to Rs 5,009 crore in FY26, a compound annual growth rate of 11.8%. Net profit grew from Rs 409 crore in FY25 to Rs 575 crore in FY26, a rise of 40.3%. In the June 2026 quarter, revenue grew 12.6% year on year to Rs 1,270 crore, while net profit rose 56.7% to Rs 165 crore. The company has a return on equity of 17.9%, a debt to equity ratio of 0.57 and a market capitalisation of Rs 9,491 crore. The stock trades at a P\/E of 15.0, below the industry P\/E of 36.0. Looking ahead, the company is leaning on new product launches in its regulated-market pipeline and improving utilisation of its plants. Profit can rise faster than revenue as volumes build on an existing cost base.\"}},{\"@type\":\"Question\",\"name\":\"How has HBL Engineering performed financially?\",\"acceptedAnswer\":{\"@type\":\"Answer\",\"text\":\"Revenue rose from Rs 1,251 crore in FY22 to Rs 3,362 crore in FY26, a compound annual growth rate of 28.0%. Net profit grew from Rs 93.7 crore in FY22 to Rs 814 crore in FY26, which works out to a compound annual growth rate of 71.7%. In the June 2026 quarter, revenue grew 6.0% year on year to Rs 659 crore. The company has a return on equity of 36.8%, a debt to equity ratio of 0.03 and a market capitalisation of Rs 22,507 crore. The stock trades at a P\/E of 28.8, below the industry P\/E of 36.9. Looking ahead, the company has grown its defence electronics and railway safety businesses, including systems for collision avoidance, and is expanding its battery lines. Orders from railways and defence customers provide a long runway.\"}},{\"@type\":\"Question\",\"name\":\"What risks should investors check before buying apparel export, pharma and defence cell stocks?\",\"acceptedAnswer\":{\"@type\":\"Answer\",\"text\":\"Investors should check a few risks before buying apparel export, pharma and defence cell stocks. Currency moves. Export earnings move with the rupee. Regulatory approvals. Plant inspections and approvals can affect supplies. Order timing. Defence and space orders can shift between periods. Reading the latest results presentation and comparing each company with its peers helps judge how these risks apply to each stock.\"}},{\"@type\":\"Question\",\"name\":\"Is this list of apparel export, pharma and defence cell stocks investment advice?\",\"acceptedAnswer\":{\"@type\":\"Answer\",\"text\":\"No. This article is educational and uses publicly available data as of the 13 November 2026 close. Please verify figures on NSE and BSE, read company filings and consult a SEBI registered adviser before investing. Univest is SEBI registered research analyst INH000013776.\"}}]}<\/script><\/div>\n","protected":false},"excerpt":{"rendered":"<p>Apparel Export, Pharma and Defence Cell Stocks with a strong future roadmap: Pearl Global Industries, Strides Pharma Science and HBL Engineering. Compare price, valuation, return on equity and revenue growth as of 13 November 2026.<\/p>\n","protected":false},"author":34,"featured_media":348565,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[845],"tags":[16087,3803,18807,24171,9056,24169,9306,24168,24170,9049],"class_list":["post-348567","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-best-stocks","tag-apparel-export","tag-best-stocks","tag-garment-exporter","tag-generics-and-power-storage-stocks","tag-hbl-engineering","tag-medicine-maker-and-cell-shares","tag-pearl-global-industries","tag-pharma-and-defence-cell-stocks","tag-readymade-garments","tag-strides-pharma-science"],"metadata":{"rank_math_internal_links_processed":["1"],"_thumbnail_id":["348565"],"rank_math_title":["Apparel Export, Pharma and Defence Battery Stocks"],"rank_math_description":["Compare 3 apparel export, pharma and defence cell stocks with a strong future roadmap on CMP, market cap, P\/E, ROE and revenue growth. Data as of 13 Nov 2026."],"rank_math_focus_keyword":["apparel export, pharma and defence cell stocks"],"rank_math_robots":["a:2:{i:0;s:7:\"noindex\";i:1;s:8:\"nofollow\";}"]},"jetpack_sharing_enabled":true,"jetpack_featured_media_url":"https:\/\/univest.in\/blogs-2\/wp-content\/uploads\/2026\/11\/3-garments-exporter-generic-pharma-maker-and-batteries-and-defence-electronics.webp","_links":{"self":[{"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/posts\/348567","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/users\/34"}],"replies":[{"embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/comments?post=348567"}],"version-history":[{"count":1,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/posts\/348567\/revisions"}],"predecessor-version":[{"id":348568,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/posts\/348567\/revisions\/348568"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/media\/348565"}],"wp:attachment":[{"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/media?parent=348567"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/categories?post=348567"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/tags?post=348567"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}